Abstract
The Radiochemistry Department of Rotem Industries produces 131I hard gelatin capsules for the treatment and diagnosis of different thyroid disorders. Each capsule is designated for a specified patient according to the physician's decision that is based on the patient's morbid status. GMP (Good Manufacturing Practices) requirements have been implemented throughout the production process resulting in the accreditation by the Israeli Ministry of Health. A computerized system has been developed and is used as a QC tool throughout the process of 131I capsule production. The request by the physician for capsules of various activities are introduced into the system and the process from production through packaging and external radiation monitoring is computer-controlled. The system prevents the possibility of double orders, out of specification production and enables documentation of data regardless of production date.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Freud, A. Production of 131I capsules: Quality control of the different stages from the physician's order to patient's administration. Journal of Radioanalytical and Nuclear Chemistry 257, 93–96 (2003). https://doi.org/10.1023/A:1024797326880
Issue Date:
DOI: https://doi.org/10.1023/A:1024797326880